VFA
DRTX

Virtus Fund Advisers’s DURATA THERAPEUTICS INC COM STK (DE) DRTX Stock Holding History

Virtus Fund Advisers’s Portfolio DRTX Stock Details DRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-1,325
Closed -$23K – 2700
2014
Q2 		$23K Buy
+1,325
New +$19.7K ﹤0.01% 2376

Other funds holding DRTX

AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CPV
Canaan Partners VII Westport, Connecticut $32.3M AUM 154.97% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
EI
EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return

Virtus Fund Advisers's DRTX Position: Q3 2014 in Review

Virtus Fund Advisers sold out of DURATA THERAPEUTICS INC COM STK (DE) (DRTX) in Q3 2014, closing a stake of 1,325 shares — an estimated $23K sold.

Virtus Fund Advisers first reported a position in DRTX in Q2 2014 and held it in 1 quarter. The position peaked at $23K in Q2 2014. 70 funds tracked by Wall St. Rank hold DRTX as of Q3 2014.

  • Virtus Fund Advisers reported no remaining DURATA THERAPEUTICS INC COM STK (DE) position as of Q3 2014 after selling out during the quarter.
  • Virtus Fund Advisers sold 1,325 DURATA THERAPEUTICS INC COM STK (DE) shares in Q3 2014, an estimated $23K.
  • Virtus Fund Advisers first reported a position in DURATA THERAPEUTICS INC COM STK (DE) in Q2 2014 and held it in 1 quarter.
  • Virtus Fund Advisers's DURATA THERAPEUTICS INC COM STK (DE) position peaked at $23K in Q2 2014.
  • 70 funds tracked by Wall St. Rank held DURATA THERAPEUTICS INC COM STK (DE) as of Q3 2014.

Based on Virtus Fund Advisers's 13F filing for Q3 2014, filed 31 Oct 2014.